1-10 of 10
Carsten Bokemeyer, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prognostic Impact of Physiological B-Cell Precursors (hematogones) in the Bone Marrow As Determined by Immunophenotyping in the Post-Transplant Period in Patients with AML

Ulrike Bacher, MD, Maximilian Christopeit, MD, Anneke Heiland, Mascha Binder, MD, Tatjana Zabelina, MD, Francis Ayuk, MD, Christiane Horn, Torsten Haferlach, MD, Carsten Bokemeyer, M.D., Nicolaus Kroeger, MD
Journal: Blood
Blood (2012) 120 (21): 1406.
https://doi.org/10.1182/blood.V120.21.1406.1406
Published: 2012
Journal Articles

Expression of Roundabout Receptor 4 (Robo-4) Confers a Negative Prognosis On Patients with Acute Myeloid Leukemia

Jasmin Wellbrock, Ph.D., Eik Vettorazzi, M.Sc., Gabi Vohwinkel, M.Sc., Thoren Müller, M.D., Marianne Klokow, Carsten Bokemeyer, M.D., Ulrike Bacher, M.D., Jürgen Krauter, MD, PhD, Walter Fiedler, MD
Journal: Blood
Blood (2012) 120 (21): 1412.
https://doi.org/10.1182/blood.V120.21.1412.1412
Published: 2012
Journal Articles

Circulating Plasma Levels of Bone Morphogenic Protein Antagonist Gremlin-1 Are Increased in Patients with Pulmonary Arterial Hypertension

Jasmin Wellbrock, Ph.D., Jan K. Hennigs, M.D., Björn Schulz, Gabi Vohwinkel, M.Sc., Hans Jörg Baumann, M.D., Carsten Bokemeyer, M.D., Hans Klose, M.D., Walter Fiedler, MD, Nicole Lüneburg, Ph. D.
Journal: Blood
Blood (2012) 120 (21): 5189.
https://doi.org/10.1182/blood.V120.21.5189.5189
Published: 2012
Journal Articles

Prognostic Significance and Target Potential of Axl in Acute Myeloid Leukemia

Alexander Schultze, M.D., M.Sc., Isabel Ben-Batalla, Ph.D., Michael Heuser, M.D., Kristoffer Weber, Ph.D., Robert Erdmann, Ph.D., Sacha Holland, Ph.D., Stefanie Sawall, Helena Fritz, M.Sc., Marc Tjwa, M.D., Ph.D., Thomas Schmidt, M.D., Walter Fiedler, M.D., Boris Fehse, Ph.D., Bjorn Dahlback, M.D., Klaus Pantel, M.D., Ph.D., Jürgen Krauter, Arnold Ganser, MD, Carsten Bokemeyer, M.D., Sonja Loges, M.D., Ph.D.
Journal: Blood
Blood (2011) 118 (21): 940.
https://doi.org/10.1182/blood.V118.21.940.940
Published: 2011
Journal Articles

Gremlin-1 Is Overexpressed in Endothelial Cells of Patients with Loeys-Dietz Syndrome Due to Dysregulation of TGF-β Signalling,

Jasmin Wellbrock, PhD, Sara Sheikhzadeh, MD, Veronika Bonk, Leticia Oliveira-Ferrer, PhD, Kristin Klaetschke, Thomas Streichert, MD, Carsten Bokemeyer, M.D., Yskert von Kodolitsch, MD, Walter Fiedler, M.D.
Journal: Blood
Blood (2011) 118 (21): 3269.
https://doi.org/10.1182/blood.V118.21.3269.3269
Published: 2011
Journal Articles

Expression of Gli2, a Downstream Mediator of the Activated Hedgehog Pathway, Represents a Negative Prognostic Marker in AML,

Walter Fiedler, M.D., Gabi Vohwinkel, MSc, Juergen Krauter, MD, Eik Vettorazzi, MSc, Sonja Loges, M.D., Ph.D., Livia Fuhrmann, Patrizia Seyfert, Carsten Bokemeyer, M.D., Jasmin Wellbrock, PhD
Journal: Blood
Blood (2011) 118 (21): 3535.
https://doi.org/10.1182/blood.V118.21.3535.3535
Published: 2011
Journal Articles

Bone Marrow Cellularity, but Not Dysplasia, Is An Additional Prognostic Factor for Patients with Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation

Maximilian Christopeit, MD, Karolin Miersch, Evgeny Klyuchnikov, MD, Mascha Binder, MD, Francis Ayuk, MD, Tatjana Zabelina, MD, Philippe Schafhausen, MD, Carsten Bokemeyer, M.D., Torsten Haferlach, MD, Nicolaus Kroeger, MD, Ulrike Bacher, MD
Journal: Blood
Blood (2011) 118 (21): 4467.
https://doi.org/10.1182/blood.V118.21.4467.4467
Published: 2011
Journal Articles

Analysis of Spontaneous Vs. Vaccine-Induced Antibody Responses Against Cancer-Testis Antigen MAGE-A3 in Cancer Patients

Yanran Cao, M.D., Sacha Gnjatic, Ph.D., Vincent G. Brichard, M.D. Ph.D., Tim Luetkens, M.D., Sebastian Kobold, M.D., Katrin Bartels, Nasser Altorki, M.D., Friedrich Haag, M.D., Gerd Ritter, M.D., Carsten Bokemeyer, M.D., Lloyd J Old, M.D., Nicolaus Kroeger, M.D., Djordje Atanackovic, M.D.
Journal: Blood
Blood (2011) 118 (21): 5087.
https://doi.org/10.1182/blood.V118.21.5087.5087
Published: 2011
Journal Articles

Simultaneous Targeting of Aurora Kinases and Bcr-Abl by the Small Molecule Inhibitor PHA-739358 Is Effective in Imatinib-Resistant Mutations Including T315I.

Artur Gontarewicz, MD, Stefan Balabanov, M.D., Ph.D., Gunhild Keller, M.D., Riccardo Colombo, Ph.D., Alessio Graziano, Ph.D, Carsten Bokemeyer, M.D., Walter Fiedler, M.D., Jurgen Moll, Ph.D., Tim Brummendorf, M.D.
Journal: Blood
Blood (2007) 110 (11): 1042.
https://doi.org/10.1182/blood.V110.11.1042.1042
Published: 2007
Journal Articles

PHA-680626 Exhibits Anti-Proliferative and Pro-Apoptotic Activity on Imatinib-Resistant Chronic Myeloid Leukemia Cell Lines and Primary CD34+ Cells by Inhibition of Both Bcr-Abl Tyrosine Kinase and Aurora Kinases.

Artur Gontarewicz, MD, Stefan Balabanov, M.D., Ph.D, Gunhild Keller, M.D., Jens Panse, M.D., Mirja Bernhardt, Carsten Bokemeyer, M.D., Walter Fiedler, M.D., Jurgen Moll, Ph.D., Tim Brummendorf, M.D.
Journal: Blood
Blood (2007) 110 (11): 4568.
https://doi.org/10.1182/blood.V110.11.4568.4568
Published: 2007